RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/23263626http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/23263626http://www.w3.org/2000/01/rdf-schema#comment"Pulmonary arterial hypertension (PAH) is characterized by vascular remodeling associated with obliteration of pulmonary arterioles and formation of plexiform lesions composed of hyperproliferative endothelial and vascular smooth-muscle cells. Here we describe a microRNA (miRNA)-dependent association between apelin (APLN) and fibroblast growth factor 2 (FGF2) signaling in pulmonary artery endothelial cells (PAECs). APLN deficiency in these cells led to increased expression of FGF2 and its receptor FGFR1 as a consequence of decreased expression of miR-424 and miR-503, which directly target FGF2 and FGFR1. miR-424 and miR-503 were downregulated in PAH, exerted antiproliferative effects in PAECs and inhibited the capacity of PAEC-conditioned medium to induce the proliferation of pulmonary artery smooth-muscle cells. Reconstitution of miR-424 and miR-503 in vivo ameliorated pulmonary hypertension in experimental models. These studies identify an APLN-dependent miRNA-FGF signaling axis needed for the maintenance of pulmonary vascular homeostasis."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.org/dc/terms/identifier"doi:10.1038/nm.3040"xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Hu X."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Kim J."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Park H."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Kang Y."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Kojima Y."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Chun H.J."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Comhair S.A."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Erzurum S.C."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Aldred M.A."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Lighthouse J.K."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"McLean D.L."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/author"Greif D.M."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/name"Nat Med"xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/pages"74-82"xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/title"An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension."xsd:string
http://purl.uniprot.org/citations/23263626http://purl.uniprot.org/core/volume"19"xsd:string
http://purl.uniprot.org/citations/23263626http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/23263626
http://purl.uniprot.org/citations/23263626http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/23263626
http://purl.uniprot.org/uniprot/Q9ULZ1#attribution-77B47AB649579EFEF052ADA8D60C1C0Fhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/23263626
http://purl.uniprot.org/uniprot/Q9ULZ1#attribution-C3D7E01F3D83143BA0FF7A8A30EA1CE9http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/23263626
http://purl.uniprot.org/uniprot/Q9ULZ1#attribution-DA6A771607EC14CD33709F28CC362F11http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/23263626